STAA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
93.5M
+0.0%
93.5M
+61.8%
57.8M
-39.0%
94.7M
+113.7%
44.3M
Cost of Revenue
23.8M
-3.5%
24.7M
+75.4%
14.1M
-16.6%
16.9M
+46.3%
11.5M
Gross Profit
69.7M
+1.3%
68.9M
+57.4%
43.7M
-43.8%
77.9M
+137.4%
32.8M
Operating Expenses
59.6M
-2.1%
60.9M
-8.6%
66.6M
+12.1%
59.4M
-5.4%
62.8M
R&D
9.9M
+0.2%
9.9M
+7.4%
9.2M
+0.4%
9.2M
-10.3%
10.3M
SG&A
49.7M
+19.6%
41.5M
-8.6%
45.4M
+2.7%
44.2M
-6.4%
47.3M
Operating Income
10.1M
+26.6%
8.0M
+134.9%
-22838000
-223.5%
18.5M
+161.7%
-29964000
EBITDA
13.4M
+4.4%
12.9M
+165.2%
-19728000
-196.2%
20.5M
+190.8%
-22594000
Net Income
8.1M
+54.8%
5.2M
+128.4%
-18309000
-306.1%
8.9M
+152.8%
-16812000
EPS (Basic)
$0.16
+60.0%
$0.10
+127.0%
$-0.37
-305.6%
$0.18
+152.9%
$-0.34
EPS (Diluted)
$0.16
+60.0%
$0.10
+127.0%
$-0.37
-305.6%
$0.18
+152.9%
$-0.34
Shares (Diluted)
51.5M
+1.2%
50.9M
+4.2%
48.9M
-3.3%
50.5M
+2.1%
49.5M
Staar Surgical (STAA) โ€” Financials